The wound irrigation systems market was valued at US$ 192.6 Mn in 2018, expected to grow at a CAGR of 3.8% during the forecast period from 2019 to 2027.
Market Insights
The global wound irrigation systems market is growing proficiently from 2019 to 2027 accredited to an increase in prevalence for chronic or acute wounds, surgical infection, pressure ulcers, traumatic wounds, and others. Increased U.S FDA approvals for new wound irrigation systems with enhanced irrigation solutions for higher patient safety and outcomes will drive the market growth. Increasing partnerships, new product launch, technology expansion and increased adoption of battery-operated systems on a global scale will contribute a significant revenue share. In Feb 2017, Centurion Medical Products launched the new wound irrigation system IRIG-8 for acute wound management in the U.S. market and internationally.
Get sample copy with covid19 impact: https://www.credenceresearch.com/sample-request/59990
According to WHO, Cancer Research UK, Medicare and other wound care fact sheets, every year more than 305 million acute, traumatic and burn wounds are recorded and treated on a global scale. In the U.S. market, diabetic foot ulcers in patients add up to around US$ 70 to US$ 80 billion in treatment costs each year. Increasing aging population and upsurges in diabetes and obesity are key factors driving the overall growth of wound care management. Increasing chronic wounds in the elderly population along with the adoption of advanced wound irrigation systems in the developed nations will further spur revenue growth during the forecast period. For e.g. top products include Igloo® wound irrigation system, IRIG-8, Irrijet wound irrigation system, Wadwand wound irrigation system, Simpulse PLUS System, and many other products are gaining traction in the international market.
The North America market dominated on a global scale attributed to increasing prevalence of diabetes, a large pool of geriatric population, increase in surgical wound infection and trauma cases along with the residence of top medical device manufacturers in U.S market. Major factors driving the market growth are an expansion of wound care management and services in home care, increasing preference for single-use products, increasing awareness associated with advanced techniques and wound care therapy in the developing nations globally.
Get sample copy with covid19 impact: https://www.credenceresearch.com/sample-request/59990
Battery operated wound irrigation systems expected to register higher growth by the end of 2027
New wound irrigation systems now comes with enhanced tip designs and compatibility with a standard care to meet all the surgical needs. Top manufacturers are receiving FDA clearance for advanced wound management. For e.g. X-Stream™ Irrigation System (C.R Bard), a laparoscopic irrigation system controller with multiple options. Battery operated show a significant growth in the developed nations in the coming years due to increase in demand for multipurpose usage for quick and enhanced output. Manual systems also contribute a larger share in the developing nations. Top products with maximum adoption in the end user segment include InterPulse, Pulsavac Plus, WinShield Wound Irrigation System and others.
Chronic wound segment to witness a significant CAGR
Increasing prevalence of chronic wounds, and growing number of hospital admissions for various lifestyle diseases will drive the market growth. In 2018, as per the statistics by WHO, Medicare and various Cancer research organizations, more than 8 million patients are living with chronic wounds in the U.S., every year incidence of chronic wounds is expected to rise at a rate of 2% in the coming 10 years. Moreover, each year Medicare spends as much as US$ 90 billion on wound treatment. Enhanced applications for solutions delivery, acute & chronic wound management, and new product launches with a variety of irrigation choices will further spur revenue growth during the forecast period.
Major players in the wound irrigation systems market are BIONIX, INC., Zimmer Biomet, Stryker Corporation, Cooper Surgical Inc., C. R. Bard, Inc., Centurion Medical Products, BSN Medical, Medtronic Plc., Westmed, Inc., UNeMed, Hopkins Medical Products, PulseCare Medical, LLC, Cardinal Health and others.
Get sample copy with covid19 impact: https://www.credenceresearch.com/sample-request/59990